ロード中...
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN
PURPOSE: Rare cancers are defined by an incidence of <6 out of 100 000 cases per year. They are under-represented in clinical research including tumour molecular analysis. The aim of Arcagen is to generate a multinational database integrating clinical and molecular information of patients with ra...
保存先:
| 出版年: | ESMO Open |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709508/ https://ncbi.nlm.nih.gov/pubmed/33262201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-001075 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|